Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crofelemer in Short Bowel Syndrome
NCT06326645Phase 1Active, not recruiting
- Sponsor
- Jessica Sosio
- Start
- Mar 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of crofelemer in short bowel syndrome (SBS), sponsored by Jessica Sosio. Primary endpoint: Ostomy output reduction at 12 weeks. Started Mar 2025; status: active, not recruiting.
02
Drugs
crofelemer
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT06326645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06326645.